{"address1": "9880 Campus Point Drive", "address2": "Suite 120", "city": "San Diego", "state": "CA", "zip": "92121", "country": "United States", "phone": "858 766 9912", "website": "https://boundlessbio.com", "industry": "Biotechnology", "industryKey": "biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "sectorKey": "healthcare", "sectorDisp": "Healthcare", "longBusinessSummary": "Boundless Bio, Inc., a clinical-stage oncology company, develops cancer therapeutics to address the unmet need of patients with oncogene amplified tumors by targeting extrachromosomal DNA. Its lead product candidate is BBI-355, an oral inhibitor of checkpoint kinase 1 that is in Phase 1/2 clinical trial in patients with oncogene amplified cancers. The company is also developing BBI-825, an oral inhibitor of ribonucleotide reductase, which is in Phase 1/2 clinical trial in cancer patients with resistance gene amplifications; and ecDTx 3 program targeting a kinesin involved with the cellular mechanism for segregation of ecDNA. Boundless Bio, Inc. was formerly known as Pretzel Therapeutics, Inc. and changed its name to Boundless Bio, Inc. in July 2019. The company was incorporated in 2018 and is headquartered in San Diego, California.", "fullTimeEmployees": 64, "companyOfficers": [{"maxAge": 1, "name": "Dr. Jonathan E. Lim M.D.", "age": 52, "title": "Co-Founder & Independent Chairman", "yearBorn": 1972, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Zachary  Hornby", "age": 45, "title": "CEO, President & Director", "yearBorn": 1979, "fiscalYear": 2023, "totalPay": 721050, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Christian  Hassig Ph.D.", "age": 51, "title": "Chief Scientific Officer", "yearBorn": 1973, "fiscalYear": 2023, "totalPay": 563550, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. David  Hinkle", "title": "Senior VP of Finance & Controller", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Jessica  Oien J.D.", "age": 53, "title": "Chief Legal Officer & Corporate Secretary", "yearBorn": 1971, "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Mr. Anthony  Pinkerton Ph.D.", "title": "Senior Vice President of Drug Discovery", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Meredith  Wesley", "title": "Senior Vice President of Talent & Culture", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Dr. Peter  Krein Ph.D.", "title": "Senior Vice President of Precision Medicine", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Amy  Berkley Ph.D.", "title": "Senior Vice President of Program Team", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}, {"maxAge": 1, "name": "Ms. Sara  Weymer", "title": "Senior Vice President of Clinical Operations", "fiscalYear": 2023, "exercisedValue": 0, "unexercisedValue": 0}], "compensationAsOfEpochDate": 1703980800, "executiveTeam": [], "maxAge": 86400, "priceHint": 4, "previousClose": 1.51, "open": 1.49, "dayLow": 1.43, "dayHigh": 1.5698, "regularMarketPreviousClose": 1.51, "regularMarketOpen": 1.49, "regularMarketDayLow": 1.43, "regularMarketDayHigh": 1.5698, "payoutRatio": 0.0, "forwardPE": -0.39509538, "volume": 53721, "regularMarketVolume": 53721, "averageVolume": 73028, "averageVolume10days": 54830, "averageDailyVolume10Day": 54830, "bid": 0.0, "ask": 1.54, "bidSize": 0, "askSize": 1, "marketCap": 32335002, "fiftyTwoWeekLow": 1.42, "fiftyTwoWeekHigh": 14.18, "fiftyDayAverage": 1.9613, "twoHundredDayAverage": 3.013625, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "currency": "USD", "tradeable": false, "enterpriseValue": -72149088, "profitMargins": 0.0, "floatShares": 14189913, "sharesOutstanding": 22300000, "sharesShort": 690330, "sharesShortPriorMonth": 415465, "sharesShortPreviousMonthDate": 1739491200, "dateShortInterest": 1741910400, "sharesPercentSharesOut": 0.031, "heldPercentInsiders": 0.11439, "heldPercentInstitutions": 0.74517, "shortRatio": 6.49, "shortPercentOfFloat": 0.0401, "impliedSharesOutstanding": 22300000, "bookValue": 6.756, "priceToBook": 0.21462405, "lastFiscalYearEnd": 1735603200, "nextFiscalYearEnd": 1767139200, "mostRecentQuarter": 1735603200, "netIncomeToCommon": -65363000, "trailingEps": -3.85, "forwardEps": -3.67, "enterpriseToEbitda": 1.0, "52WeekChange": -0.8921933, "SandP52WeekChange": 0.08089435, "quoteType": "EQUITY", "currentPrice": 1.45, "targetHighPrice": 15.0, "targetLowPrice": 15.0, "targetMeanPrice": 15.0, "targetMedianPrice": 15.0, "recommendationMean": 2.0, "recommendationKey": "buy", "numberOfAnalystOpinions": 1, "totalCash": 152114000, "totalCashPerShare": 6.822, "ebitda": -72181000, "totalDebt": 47632000, "quickRatio": 18.699, "currentRatio": 18.978, "debtToEquity": 31.619, "returnOnAssets": -0.27233, "returnOnEquity": -0.48207, "freeCashflow": -37578876, "operatingCashflow": -60841000, "grossMargins": 0.0, "ebitdaMargins": 0.0, "operatingMargins": 0.0, "financialCurrency": "USD", "symbol": "BOLD", "language": "en-US", "region": "US", "typeDisp": "Equity", "quoteSourceName": "Nasdaq Real Time Price", "triggerable": true, "customPriceAlertConfidence": "HIGH", "cryptoTradeable": false, "hasPrePostMarketData": true, "firstTradeDateMilliseconds": 1711632600000, "marketState": "PRE", "regularMarketChangePercent": -3.973506, "regularMarketPrice": 1.45, "shortName": "Boundless Bio, Inc.", "longName": "Boundless Bio, Inc.", "regularMarketChange": -0.059999943, "regularMarketDayRange": "1.43 - 1.5698", "fullExchangeName": "NasdaqGS", "averageDailyVolume3Month": 73028, "fiftyTwoWeekLowChange": 0.03000009, "fiftyTwoWeekLowChangePercent": 0.021126825, "fiftyTwoWeekRange": "1.42 - 14.18", "fiftyTwoWeekHighChange": -12.7300005, "fiftyTwoWeekHighChangePercent": -0.89774334, "fiftyTwoWeekChangePercent": -89.21933, "epsTrailingTwelveMonths": -3.85, "epsForward": -3.67, "epsCurrentYear": -3.23667, "priceEpsCurrentYear": -0.4479913, "fiftyDayAverageChange": -0.51129997, "fiftyDayAverageChangePercent": -0.2606944, "twoHundredDayAverageChange": -1.5636249, "twoHundredDayAverageChangePercent": -0.5188519, "sourceInterval": 15, "exchangeDataDelayedBy": 0, "ipoExpectedDate": "2024-03-28", "averageAnalystRating": "2.0 - Buy", "corporateActions": [], "regularMarketTime": 1743537601, "exchange": "NMS", "messageBoardId": "finmb_637641859", "exchangeTimezoneName": "America/New_York", "exchangeTimezoneShortName": "EDT", "gmtOffSetMilliseconds": -14400000, "market": "us_market", "esgPopulated": false, "trailingPegRatio": null}